National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

iodine I 124 chimeric monoclonal antibody G250
A radioimmunoconjugate comprised of the chimeric monoclonal antibody G250 conjugated with the positron emitter iodine I 124. The antibody moiety of iodine I 124 chimeric monoclonal antibody G250 may bind to renal cell carcinoma (RCC) cells that express the RCC-associated antigen G250, allowing detection of tumor-localized iodine I 124 with positron emission tomography (PET). G250 is a cell surface tumor-associated antigen (TAA) that is found in the majority of renal cell carcinomas. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:iodine 131-6-beta-iodomethyl-19-norcholesterol, iodine I 123, iodine I 123 anti-CEA recombinant diabody T84.66, iodine I 123 iodometomidate, iodine I 124
Next:iodine I 124 iodo-azomycin galactopyranoside, iodine I 124 iododeoxyuridine, iodine I 125, iodine I 125 anti-EGFR-425 monoclonal antibody, iodine I 131

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov